If an advanced approach is appropriate, the National Guidelines (Social Board 2016 and 2022) recommend that the issue be addressed at a multi-disciplinary conference (MDK round) held at the regional motoring units.
The general recommendations are that if you have untreated symptoms with a significant impact on your ability to cope with everyday life and have the ability/ ability to adapt to an advanced treatment and in the absence of the contraindications to pump or DBS treatments, you should be referred for a discussion and/ or assessment. It is often stated that you should have an ” optimal treatment ” and have at least 5 doses of regular anti-Parkinson medication, 2 hours of painful ” off-periods ” and at least 1 hour of medical treatment, but it is not necessary to have tested all medicines.
ProDuodopa is a new pump-based medicinal product, where a more stable treatment effect can be achieved with tex fluctuations, but there are some risks and complications with this treatment when the medicinal product is given under the skin with a pump. The drug is highly concentrated and can cause skin reactions, and can also affect the skin barrier and lead to infections. It is also sometimes difficult to obtain a stable effect, which is why it is necessary to assess whether there is a likelihood of achieving a beneficial treatment effect before starting the process of testing. /Hocan Widner